Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Current Vascular Pharmacology|June 26, 2012
Novel antiplatelet therapy in acute coronary syndromes: what is new in the pipeline?Karin A L Müller, Tobias GeislerHamostaseologie|March 29, 2018
Elinogrel, an orally and intravenously available ADP-receptor antagonistK A L Müller, T Geisler, M GawazHamostaseologie|July 10, 2012
Elinogrel, an orally and intravenously available ADP-receptor antagonist. How does elinogrel affect a personalized antiplatelet therapy?K A L Müller, T Geisler, M GawazContraception|May 14, 2003
Postcoital treatment with levonorgestrel does not disrupt postfertilization events in the ratA L Müller, C M Llados, H B CroxattoThrombosis and Haemostasis|July 31, 2015
Platelets, inflammation and anti-inflammatory effects of antiplatelet drugs in ACS and CADKarin A L Müller, Madhumita Chatterjee, Dominik Rath, et al.JDR Clinical and Translational Research|August 7, 2025
Recruiting Dental Practices for Research: Insights from a Practice-Based Trial in GermanyP Hennrich, V Fehrer, A L Müller, et al.Plos One|February 26, 2013
Prognostic value of contrast-enhanced cardiac magnetic resonance imaging in patients with newly diagnosed non-ischemic cardiomyopathy: cohort studyKarin A L Müller, Iris Müller, Ulrich Kramer, et al.Clinical Cardiology|April 22, 2016
High Plasma Levels of Gremlin-1 and Macrophage Migration Inhibitory Factor, but Not Their Ratio, Indicate an Increased Risk for Acute Coronary Syndrome in Patients With Type 2 Diabetes MellitusKarin A L Müller, Dominik Rath, Martina Schmid, et al.European Journal of Clinical Investigation|March 17, 2021
Protective role of Gremlin-1 in myocardial functionIris I Müller, Martina Schneider, Karin A L Müller, et al.Clinical Cardiology|March 22, 2023
Deceleration capacity of heart rate predicts 1-year mortality in patients undergoing transcatheter edge-to-edge mitral valve repairLars Mizera, Dominik Rath, Jürgen Schreieck, et al.Pageof 3